Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
Data up to Jan 2025
Total Citations Per Year
Abstract
References (112)
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
1991 • 3,309 citations
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
1997 • 3,094 citations
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 • 2,561 citations
Caspases: Intracellular Signaling by Proteolysis
1997 • 2,114 citations
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
1995 • 1,576 citations
Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
1995 • 1,528 citations
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
1990 • 1,423 citations
The matrix‐degrading metalloproteinases
1992 • 1,383 citations
ECM and Cell Surface Proteolysis: Regulating Cellular Ecology
1997 • 1,311 citations
COLLAGENOLYTIC ACTIVITY IN AMPHIBIAN TISSUES: A TISSUE CULTURE ASSAY
1962 • 1,275 citations
SV40-transformed Human Lung Fibroblasts Secrete a 92-kDa Type IV Collagenase Which Is Identical to That Secreted by Normal Human Macrophages
1989 • 1,122 citations
Proteolytic remodeling of extracellular matrix
1995 • 1,086 citations
Immunological Aspects of Demyelinating Diseases
1992 • 1,021 citations
The T Lymphocyte in Experimental Allergic Encephalomyelitis
1990 • 1,005 citations
Tissue-plasminogen activator is induced as an immediate–early gene during seizure, kindling and long-term potentiation
1993 • 841 citations
The adhesion molecule and cytokine profile of multiple sclerosis lesions
1995 • 761 citations
Regulation of Integrin Function by the Urokinase Receptor
1996 • 734 citations
Concepts and Principles of O-Linked Glycosylation
1998 • 730 citations
Endogenous Activation of Latent Collagenase by Rheumatoid Synovial Cells
1977 • 686 citations
Matrix metalloproteinases and diseases of the CNS
1998 • 646 citations
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
1997 • 629 citations
Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
1992 • 620 citations
The Matrix Metalloproteinases and Their Inhibitors
1992 • 604 citations
Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
1992 • 519 citations
T cell gelatinases mediate basement membrane transmigration in vitro.
1995 • 507 citations
Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
1987 • 474 citations
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
1997 • 472 citations
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
1993 • 467 citations
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
1996 • 460 citations
Glycosylation: Heterogeneity and the 3D Structure of Proteins
1997 • 422 citations
Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation
1977 • 389 citations
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS
1994 • 366 citations
Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9
1996 • 363 citations
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
1994 • 342 citations
Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
1994 • 338 citations
The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion
1997 • 326 citations
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
1995 • 324 citations
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
1996 • 306 citations
Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
1996 • 302 citations
Matrix metalloproteinases degrade myelin basic protein
1995 • 291 citations
Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions
1996 • 290 citations
Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
1992 • 286 citations
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination
1978 • 276 citations
Animal models
1994 • 276 citations
Fibrinolysis in the Animal Organism
1947 • 265 citations
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
1997 • 265 citations
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
1998 • 262 citations
Purification and identification of 91‐kDa neutrophil gelatinase
1991 • 259 citations
Plasminogen activator–plasmin system and neuronal migration
1982 • 256 citations
The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis
1996 • 247 citations
uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?
1997 • 246 citations
Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization
1993 • 239 citations
Chemotaxis by a CNS macrophage, the microglia
1990 • 215 citations
Cytokine-regulated proteases in autoimmune diseases
1994 • 214 citations
Extracellular Matrix‐Degrading Proteinases in the Nervous System
1994 • 208 citations
Concepts and principles of glycobiology
1993 • 206 citations
T cell recognition of carbohydrates on type II collagen.
1994 • 206 citations
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor
1997 • 205 citations
Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.
1993 • 196 citations
Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
1993 • 192 citations
Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.
1994 • 184 citations
Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein
1993 • 181 citations
Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression.
1994 • 180 citations
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS
1998 • 179 citations
Expression of immunologically relevant endothelial cell activation antigens on isolated central neurvous system microvessels from patients with multiple sclerosis
1994 • 170 citations
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
1998 • 166 citations
The molecular basis of leukocytosis
1998 • 161 citations
Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer
1992 • 160 citations
Immunologic Mechanisms and Therapy in Multiple Sclerosis
1995 • 147 citations
Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
1995 • 146 citations
Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix
1998 • 143 citations
The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate
1988 • 142 citations
Microglia isolated from rat brain secrete a urokinase-type plasminogen activator
1992 • 127 citations
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
1998 • 124 citations
Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat
1993 • 114 citations
Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis
1980 • 114 citations
Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.
1996 • 110 citations
Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules
1992 • 107 citations
Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.
1991 • 107 citations
Inflammation in the nervous system. Basic mechanisms and immunological concepts.
1991 • 100 citations
Monoclonal Antibodies Specific for Natural Human Neutrophil Gelatinase B Used for Affinity Purification, Quantitation by Two‐Site ELISA and Inhibition of Enzymatic Activity
1995 • 100 citations
Matrix metalloproteinases MMP‐9 and MMP‐7 are expressed in experimental autoimmune neuritis and the guillain‐barré syndrome
1998 • 95 citations
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.
1996 • 95 citations
Mouse gelatinase B
1993 • 93 citations
The Extracellular Matrix in Multiple Sclerosis Lesions
1998 • 83 citations
Matrix metalloproteinase expression during experimental autoimmune neuritis
1998 • 83 citations
Production and regulation of gelatinase B by human T-cells
1993 • 80 citations
Cells regulate the activities of cytokines by glycosylation
1995 • 78 citations
Vitronectin and Integrin Vitronectin Receptor Localization in Multiple Sclerosis Lesions
1995 • 75 citations
Evaluation of gelatinases and IL‐6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
1994 • 74 citations
Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases
1996 • 69 citations
Interleukin 1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes
1987 • 63 citations
Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees.
1996 • 63 citations
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
1994 • 60 citations
mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation
1997 • 56 citations
Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain
1996 • 55 citations
The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease
1991 • 54 citations
Biochemistry of Demyelination
1996 • 42 citations
Production and Characterization of Recombinant Active Mouse Gelatinase B from Eukaryotic Cells and in vivo Effects after Intravenous Administration
1997 • 41 citations
Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine
1995 • 40 citations
Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia
1996 • 38 citations
The Activation of Type 1 and Type 2 Plasminogen by Type I and Type II Tissue Plasminogen Activator
1995 • 37 citations
Cytokine and Protease Glycosylation as a Regulatory Mechanism in Inflammation and Autoimmunity
1998 • 34 citations
Components of the Plasminogen Activator System in Astrocytes Are Modulated by Tumor Necrosis Factor‐α and Interleukin‐1β Through Similar Signal Transduction Pathways
1995 • 32 citations
Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
1997 • 23 citations
Toxicity in a double-blind, placebo-controlled pilot trial with D-penicillamine and metacycline in secondary progressive multiple sclerosis
1998 • 21 citations
Increased axon growth through astrocyte cell lines transfected with urokinase.
1998 • 19 citations
Increased axon growth through astrocyte cell lines transfected with urokinase
1998 • 15 citations
Cloning and expression in Escherichia coli of a human gelatinase B‐inhibitory single‐chain immunoglobulin variable fragment (scFv)
1997 • 14 citations
Formation of a covalent Hg‐Cys‐bond during mercurial activation of PMNL procollagenase gives evidence of a cysteine‐switch mechanism
1992 • 13 citations
[The T-lymphocyte].
1997 • 10 citations
On the Regulation of EAE
1993 • 10 citations
Cited By (0)
No citing papers found in database